NovaBridge Biosciences Increase Decrease In Operating Lease Liability
NovaBridge Biosciences (NBP) reported Increase Decrease In Operating Lease Liability of -$816.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-04-07
- NovaBridge Biosciences increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$208.00K.
- NovaBridge Biosciences increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$206.00K.
- NovaBridge Biosciences increase decrease in operating lease liability for the quarter ending 2024-12-31 was -$180.00K.
- NovaBridge Biosciences increase decrease in operating lease liability for the quarter ending 2024-09-30 was -$178.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$208.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | -$414.00K derived: sum of 2 quarters · filed 2026-04-07 | -$816.00K 20-F · filed 2026-04-07 | |
| 2025-09-30 | -$206.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | -$608.00K 6-K · filed 2025-12-18 | ||
| 2025-06-30 | -$402.00K 6-K · filed 2025-10-06 | |||
| 2024-12-31 | -$180.00K derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | -$358.00K derived: sum of 2 quarters · filed 2026-04-07 | -$588.00K 20-F · filed 2026-04-07 | |
| 2024-09-30 | -$178.00K derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18 | -$408.00K 6-K · filed 2025-12-18 | ||
| 2024-06-30 | -$230.00K 6-K · filed 2025-10-06 | |||
| 2023-12-31 | -$575.00K 20-F · filed 2026-04-07 | |||
| 2022-12-31 | -$1.22M 20-F · filed 2025-04-03 |